x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

IDEA Collider: Innovation & Asymmetric Learning in Pharma

IDEA Pharma, SAI MedPartners

IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma & Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare. Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and

science life sciences

All Episodes

00:47:23

Asymmetric Learning in Cybersecurity & Intelligence...

IDEA Collider: Innovation & Asymmetric Learning in... ·

2022/10/05

Welcome to another fantastic episode of the IDEA Collider│Asymmetric learning series with your host Mike Rea. Today we are joined by Gene Yoo, the Chief Executive Officer at Resecurity, Inc. He talks about asymmetric learning in cybersecurity & Intelligence and what gives Resecurity an edge over other competitors in the marketMoreover, he shares about the signal validation process at Resecurity, how to understand the vulnerability of your business and what you need to combat cyber threats. In

en

00:58:33

Where Do Good Ideas Come from? With Steven Johnson

IDEA Collider: Innovation & Asymmetric Learning in... ·

2022/09/28

Welcome to another fantastic episode of the IDEA Collider│Asymmetric learning series with your host Mike Rea. In today’s episode, Mike interviews Steven Johnson, an author of 13 books, a TV host, and a podcaster. He talks about Innovation vs. Invention and explains where good ideas come from. Additionally, Steven talks about the Individual and organizational hunch collection tools and shares how organizational culture impacts innovation. Moreover, he talks about his books The Ghost Map and

en

00:00:47

Welcome Back to Series II of IDEA Collider

IDEA Collider: Innovation & Asymmetric Learning in... ·

2022/09/28

en

00:58:06

Sick Money: The Truth About The Global Pharmaceutical...

IDEA Collider: Innovation & Asymmetric Learning in... ·

2022/06/22

Welcome to another fantastic episode of the IDEA Collider│Pharma Book Club series with your host Mike Rea. Today we are joined by Billy Kenber, an investigative journalist at “The Times.” He talks about his journey to writing his book ‘Sick Money’ and the content in the book.Additionally, he talks about the pharmaceutical industry’s social contract with patients and how its distortion has led to pharmaceutical greed. Moreover, he shares how the culture within the pharmaceutical industry has changed,

en

00:52:11

IDEA Collider | Kabir Nath

IDEA Collider: Innovation & Asymmetric Learning in... ·

2021/08/26

Kabir Nath is President & CEO, Otsuka North America Pharmaceutical Business Throughout his career, Kabir has built bridges between cultures. His work has taken him across the globe, spanning 3 continents and multiple countries. Kabir has lived and worked in the United Kingdom, France, Spain, India, Singapore, China, and the United States. He has consistently inspired those around him to go beyond cultural and linguistic differences to bring new concepts and ideas to life, forging stronger

en

00:47:42

IDEA Collider | Pharma Book Club | Kat Arney

IDEA Collider: Innovation & Asymmetric Learning in... ·

2021/08/13

(Now also released in paperback: https://amzn.to/3lWjo2B) Kat can be found at First Create The Media: and on Twitter: @Kat_Arney Find out more about Rebel Cell here: https://www.rebelcellbook.com/about-rebel-cell-cancer-bookMany of us think of cancer as a contemporary killer, a disease of our own making caused by our modern lifestyles. But, as Kat Arney explains in her new book REBEL CELL: Cancer Evolution and the Science of Life, that perception just isn’t true. Although it might be rare in many

en

00:51:22

IDEA Collider | Susanne Schaffert, PhD

IDEA Collider: Innovation & Asymmetric Learning in... ·

2021/07/30

As President of Novartis Oncology, Susanne Schaffert is pursuing a bold strategy to reimagine the research, development and commercialization of innovative treatments that will help improve and extend the lives of people with cancer and related blood disorders. Susanne has held positions of increasing seniority across a range of business areas during her career at Novartis, having first joined the company as a sales representative in Germany in 1995. The majority of her roles have been in oncology,

en

00:49:02

IDEA Collider | Dan Skovronsky

IDEA Collider: Innovation & Asymmetric Learning in... ·

2021/05/24

Dan Skovronsky is the chief scientific officer of Eli Lilly and Company. He serves as senior vice president of science and technology and president of Lilly Research Laboratories. He also has responsibility for global business development. Dan joined Lilly in 2010 when the company acquired Avid Radiopharmaceuticals Inc., where he had been CEO since founding the company in 2004. At Lilly, Dan has held various roles, including vice president, tailored therapeutics; vice president, diabetes research;

en

00:50:06

IDEA Collider | Pharma Book Club | Brian Christian

IDEA Collider: Innovation & Asymmetric Learning in... ·

2021/02/23

With so much at stake in the application of AI/ Machine Learning to pharma, biotech and medicine, this wonderful book touches on biases, systems of learning, and the choices we have to make to properly harness the power of what is possible. Email mike at ideapharma.com to enter a lottery to win a copy of the hardcover book, closing date 26th February.From the page at brianchristian.org: A jaw-dropping exploration of everything that goes wrong when we build AI systems and the movement to fix them

en

00:42:15

IDEA Collider | Nick Wood, Benji Compston

IDEA Collider: Innovation & Asymmetric Learning in... ·

2021/02/11

Syn is an award winning music agency and creative solutio, providing music strategy, composition, sound design and sonic branding for advertising, cinema and television, as well as music supervision, licensing and music curation services and our studios record voiceover, ADR and narration.In this interview, we discuss the user experience (patient, physician), via sound, for healthcare and pharma environmentsMore information at https://syn.world

en

00:42:39

IDEA Collider | Riccardo Zacconi

IDEA Collider: Innovation & Asymmetric Learning in... ·

2021/01/26

Great interview with Riccardo on CNBCFind out more about PTEN Research at https://www.ptenresearch.org

en

00:45:20

IDEA Collider | John Tsai, MD

IDEA Collider: Innovation & Asymmetric Learning in... ·

2021/01/18

Covering a wide variety of topics, with a special focus on Novartis as one of the best examples of a learning organisation in pharma. On cultures of innovation, 'unbossing', decision making and measuring what matters John can be found on LinkedIn: https://www.linkedin.com/in/john-tsai-md-ab398b4/ or contacted by email at john_tsai.office at novartis.com

en

00:45:27

IDEA Collider | Andy Coravos and Jen Goldsack, The...

IDEA Collider: Innovation & Asymmetric Learning in... ·

2020/12/07

A discussion of The Playbook, from DiMe Society, Digital Clinical Measures Introducing the essential industry guide for successfully developing & deploying digital clinical measures across clinical research, clinical care, and public health https://playbook.dimesociety.org More on Andy (Andrea) Coravos here: http://www.andreacoravos.com More on Jen (Jennifer) Goldsack here: https://en.wikipedia.org/wiki/Jennifer_Goldsack More on DiMe Society here: https://www.dimesociety.org

en

00:46:48

IDEA Collider | Carinne Brouillon, Edward Hæggström,...

IDEA Collider: Innovation & Asymmetric Learning in... ·

2020/11/30

Carinne Brouillon is a Member of the Board of Managing Directors, with responsibility for the Human Pharma Business Unit Professional milestones 2018 – 2019 Global Head of Therapeutic Areas, Boehringer Ingelheim 2014 – 2018 Head of Global Commercial Strategy Neuroscience at Janssen, Johnson & Johnson’s Pharmaceutical Company 2012 – 2018 President of Janssen Therapeutics and Member of the Janssen North America Leadership Team Edward Hæggström Born 1969. Finnish citizen. Co-founder of Nanoform, CEO

en

00:32:09

IDEA Collider | Defining and Measuring Innovation

IDEA Collider: Innovation & Asymmetric Learning in... ·

2020/11/10

This episode replays some of a round table we held at JP Morgan, back when people used to travel... It features the voices of Mike Rea, in conversation with Linda Avey, Co-founder of 23andMe, and Curious, Inc, Amrit Chaudhuri, CEO, Mass Innovation Labs (now SmartLabs), Steve Holtzman, then CEO, Decibel Therapeutics, Raj Kannan then SVP, Global Franchise Head, Neurology & Immunology, EMD Serono, Michael Schrage, Research Fellow, MIT Center for Digital Business; Visiting Fellow, Imperial College

en

00:46:01

IDEA Collider | Pharma Book Club | Lee Vinsel and...

IDEA Collider: Innovation & Asymmetric Learning in... ·

2020/09/29

ABOUT THE INNOVATION DELUSION Innovation is the hottest buzzword in business. But what if our obsession with finding the next big thing has distracted us from the work that matters most? “The most important book I’ve read in a long time . . . It explains so much about what is wrong with our technology, our economy, and the world, and gives a simple recipe for how to fix it: Focus on understanding what it takes for your products and services to last.”—Tim O’Reilly, founder of O’Reilly Media It’s hard

en

00:59:00

IDEA Collider | Dr Peter Bach

IDEA Collider: Innovation & Asymmetric Learning in... ·

2020/09/01

Peter B. Bach is a physician, epidemiologist, researcher, and respected healthcare policy expert whose work focuses on the cost and value of anticancer drugs. Dr. Bach is leading efforts to increase understanding of the US drug development process and develop new models for drug pricing that include value to patients Dr. Bach described a 100-fold increase in cancer drug prices since 1965 after adjusting for inflation, and that the cost of an additional year of life from a cancer treatment increases

en

00:46:26

IDEA Collider | Jen Horonjeff

IDEA Collider: Innovation & Asymmetric Learning in... ·

2020/08/25

In conversation, discussing patient input into clinical programs, unmet need assessments, measurement and so much more.Jen was diagnosed with juvenile arthritis as an infant and now has a laundry list of other conditions and surprises (like a brain tumor). She is passionate about elevating and valuing the patient voice, and went on to become a health outcomes researcher, human factors engineer, FDA Consumer Representative, and, most importantly, a patient advocate. Jen earned a PhD in Environmental

en

00:57:55

IDEA Collider | Pharma Book Club | Gerald Posner

IDEA Collider: Innovation & Asymmetric Learning in... ·

2020/08/09

From the Amazon description: Pharmaceutical breakthroughs such as antibiotics and vaccines rank among some of the greatest advancements in human history. Yet exorbitant prices for life-saving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on prescription opioids have caused many to lose faith in drug companies. Now, Americans are demanding a national reckoning with a monolithic industry. Pharma introduces brilliant scientists,

en

00:45:52

IDEA Collider | Daphne Zohar

IDEA Collider: Innovation & Asymmetric Learning in... ·

2020/08/06

PureTech Health is an advanced, clinical-stage biopharmaceutical company developing novel medicines targeting serious diseases that result from dysfunctions in the nervous, immune, and gastrointestinal systems (brain-immune-gut or the “BIG” axis), which together represent the adaptive human systems. PureTech Health is at the forefront of understanding and addressing the biological processes and crosstalk associated with the BIG axis. By harnessing this emerging field of human biology, the Company is

en

60 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter